Nestlé to launch line of pizzas aimed at people taking weight loss drugs

Roughly one in eight US adults have taken the appetite-suppressing drugs

Nestle said that it has been working on a range of products which have more protein, iron, and calcium since last year. They will be marketed towards people on medications such as Wegovy or Ozempic. 

Food giant Nestlé has said it will market a new $5 (€4.60) line of frozen pizzas in the US which are designed specifically for people taking weight loss drugs such as Wegovy or Ozempic.

The company, which sells DiGiorno pizza and Stouffer's meals to major grocers, said it developed the new products with more protein, iron and calcium for people taking the wildly popular appetite-suppressing drugs, called GLP-1 agonists.